Cingulate Inc. (CING): Nasdaq/NYSE listing notice — Cingulate receives Nasdaq delisting notice for continued non-compliance with equity rule; intends to request hearing
Cingulate Inc.
Nasdaq staff determined to delist CING common stock and warrants unless a hearing is timely requested.
Company failed to regain compliance with $2.5M minimum stockholders' equity by Nov 13, 2023 deadline.
Company intends to request a hearing before Nasdaq Hearings Panel to seek an extension.
Also noted separate bid price deficiency; compliance period extends to Jan 24, 2024.
If delisted, liquidity and capital access could be materially adversely affected.
Cingulate Inc. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).
Exchange
nasdaq
Notice
delisting notice
Deficiency
stockholders equity
Rules
5550(b)(1)
Exact text from the filing
November 14, 2023, Cingulate Inc. (the “Company”) received a letter from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the Company’s continued non-compliance with the minimum stockholders’ equity requirement in Listing Rule 5550(b)(1) (the “Minimum Stockholders’ Equity Rule”) for continued listing on The Nasdaq Capital Market, the Staff had determined to delist the Company’s securities from Nasdaq unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the “Panel”). The Company intends to timely reque
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.